# A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Maraviroc Therapy

> **NCT00870363** · PHASE4 · COMPLETED · sponsor: **University of California, Davis** · enrollment: 44 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** maraviroc in combination with 2 NRTIs (dual nucleoside reverse transcriptase inhibitor)
- **DRUG:** maraviroc plus raltegravir in combination with 2 NRTIs (dual nucleoside reverse transcriptase inhibitor)
- **DRUG:** efavirenz [or other NNRTI (non-nucleoside reverse transcriptase inhibitor)]

## Key facts

- **NCT ID:** NCT00870363
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00870363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00870363, "A Pilot Project of Virologic, Pharmacologic and Immunologic Correlates of Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution Following Maraviroc Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00870363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*